Product Detail

CARDIO-DIABETIC

GLIMIMED V

GLIMIPRIDE 2MG METFORMIN 500MG SR VOGLIBOSE 0.2MG BILAYERED TAB

Glimepiride 2mg + Metformin 500mg SR + Voglibose 0.2mg is a fixed-dose combination drug that controls type 2 diabetes.

Glimepiride 2mg + Metformin 500mg SR + Voglibose 0.2mg is a fixed-dose combination drug that controls type 2 diabetes. The drug controls blood sugar by activating the secretion of insulin, inhibiting the production of glucose, enhancing insulin sensitivity, and slowing down the absorption of carbohydrates, avoiding sudden increases in blood sugar following food intake.

MRP: ₹2050/-

100%

Certified Products

Secure

pAYMENTS

24/7

Customer Support

100%

Certified Products

Secure

PAYMENTS

24/7

Customer Support

About The Product

Uses

Glimepiride 2mg + Metformin 500mg SR + Voglibose 0.2mg is a fixed-dose combination drug that controls type 2 diabetes. The drug controls blood sugar by activating the secretion of insulin, inhibiting the production of glucose, enhancing insulin sensitivity, and slowing down the absorption of carbohydrates, avoiding sudden increases in blood sugar following food intake.

Side Effects

  • Nausea, bloating, or discomfort in the stomach.
  • Hypoglycemia (low blood sugar) with dizziness or perspiration.
  • Diarrhea or mild gastrointestinal disturbance.
  • Flatulence as a result of the activity of Voglibose.

Indications

  • Effective control of blood sugar in type 2 diabetes.
  • Improves glucose metabolism and insulin secretion.
  • Decreases post-meal blood sugar rise by delaying carbohydrate absorption.
  • Decreases the risk of diabetic complications.

FAQ

Q1. What is the mechanism of this combination in diabetes?
Ans. Glimepiride increases insulin secretion, Metformin decreases glucose production, and Voglibose delays carbohydrate absorption, maintaining stable blood sugar levels.

Q2. At what time should I take this tablet?
Ans. It must be taken before or with meals to achieve optimal effectiveness in suppressing blood sugar surges.

Q3. Can this drug lead to low blood sugar?
Ans. Yes, particularly when taken on an empty stomach or with other diabetes drugs. Blood sugar should be monitored regularly.

Q4. Is it safe to take for the long term?
Ans. Yes, provided there is ongoing blood sugar monitoring and assessment of kidney function to ensure safe and effective treatment.

Indications

  • Effective control of blood sugar in type 2 diabetes.
  • Improves glucose metabolism and insulin secretion.
  • Decreases post-meal blood sugar rise by delaying carbohydrate absorption.
  • Decreases the risk of diabetic complications.

FAQ

Q1. What is the mechanism of this combination in diabetes?
Ans. Glimepiride increases insulin secretion, Metformin decreases glucose production, and Voglibose delays carbohydrate absorption, maintaining stable blood sugar levels.

Q2. At what time should I take this tablet?
Ans. It must be taken before or with meals to achieve optimal effectiveness in suppressing blood sugar surges.

Q3. Can this drug lead to low blood sugar?
Ans. Yes, particularly when taken on an empty stomach or with other diabetes drugs. Blood sugar should be monitored regularly.

Q4. Is it safe to take for the long term?
Ans. Yes, provided there is ongoing blood sugar monitoring and assessment of kidney function to ensure safe and effective treatment.

Take the First Step – Contact Us!

Apply Now For PCD Pharma Franchise!

Take the First Step – Contact Us!

Apply for Pharma Franchise Now.
Don’t Post Here Job query. 

Do You Have Drug License?